[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-411283-105":59,"doc-detail-411283-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pharmacological-treatment-for-apnoea-of-prematurity-the-need-for-an-individualised-approach","Pharmacological treatment for apnoea of prematurity - the need for an individualised approach","","Pharmacological treatment for apnea of prematurity is evaluated with a focus on why individualized approaches are needed. The article discusses outcomes, risk-benefit considerations, and how treatment selection may depend on specific patient characteristics. It highlights clinical reasoning regarding therapeutic goals, dosing and monitoring, and the implications for practice. Published in 2025, it provides an expert perspective aligned with evolving evidence and supports tailored decision-making for infants at risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pharmacological-treatment-for-apnoea-of-prematurity-the-need-for-an-individualised-approach/411283/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pharmacological-treatment-for-apnoea-of-prematurity-the-need-for-an-individualised-approach/411283.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-28",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is an individualized pharmacological approach important for apnea of prematurity?","Question",{"text":112,"@type":113},"Because treatment decisions need to account for patient-specific risk factors and therapeutic goals, balancing expected benefits against potential harms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What factors are considered when choosing pharmacological therapy?",{"text":117,"@type":113},"The article emphasizes clinical reasoning around outcomes, dosing considerations, and monitoring needs tailored to the individual infant.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the article apply its conclusions to clinical practice?",{"text":121,"@type":113},"It frames individualized decision-making as a practical requirement, supporting clinicians to select and supervise treatment in line with evolving evidence and patient characteristics.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},411283,1791386531,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","􀀚Y􀀁E R􀀍􀀌􀀄􀀍􀀝  \n􀀁UBLISHED 18 D􀀍􀀅􀀍􀀜b􀀍􀀃 2025 D􀀗I 10.3389/􀀑􀀚􀀍d.2025.1710569  \n􀀁􀀂􀀃􀀄􀀁􀀂 􀀆􀀇  \n􀀁􀀂􀀃􀀄􀀅􀀆 􀀈􀀆􀀅􀀅􀀉􀀄􀀊  \n􀀋􀀂􀀄􀀌􀀍􀀃􀀎􀀄􀀏􀀐 􀀆􀀑 􀀒􀀆􀀓􀀆􀀔􀀂􀀕􀀊 􀀖􀀏􀀕􀀓􀀐  \n􀀈􀀁􀀉􀀃􀀁􀀊􀀁􀀂 􀀆􀀇  \n􀀗􀀘􀀆􀀎 􀀙􀀕􀀎􀀚􀀕􀀃􀀄􀀅􀀎􀀊  \n􀀛􀀍􀀜􀀜􀀍􀀓􀀝􀀍􀀄􀀎 􀀋􀀂􀀄􀀌􀀍􀀃􀀎􀀄􀀏􀀐􀀊 􀀞 􀀂􀀔􀀕􀀃􀀐 R􀀆b􀀍􀀃􀀏􀀕 P􀀕􀀃􀀓􀀕d􀀆􀀃􀀄􀀊  \n􀀖R􀀈􀀈􀀛 􀀋􀀂􀀄􀀌􀀍􀀃􀀎􀀄􀀏􀀐 􀀞􀀆􀀎􀀚􀀄􀀏􀀕􀀓 􀀆􀀑 􀀒􀀆􀀓􀀆􀀔􀀂􀀕 􀀛􀀕􀀂􀀏 O􀀃􀀎􀀆􀀓􀀕 P􀀆􀀓􀀐􀀅􀀓􀀄􀀂􀀄􀀅􀀊 􀀖􀀏􀀕􀀓􀀐  \n*􀀋􀀌􀀈􀀈􀀁􀀍􀀎􀀌􀀏􀀂􀀁􀀏􀀋􀀁  \n􀀈􀀕􀀃􀀆􀀓􀀄􀀂􀀍 􀀞􀀕􀀃􀀏􀀓􀀍􀀐  \n 􀀅􀀕􀀃􀀆􀀓􀀄􀀂􀀍 . 􀀉􀀕􀀃􀀏􀀓􀀍􀀐@􀀚􀀕􀀍d􀀄􀀕􀀏􀀃􀀄􀀅􀀎 .􀀆x.􀀕􀀅 . 􀀘†T􀀉􀀍􀀎􀀍 􀀕 􀀏􀀉􀀆􀀃􀀎 􀀉􀀕􀀌􀀍 􀀅􀀆􀀂􀀏􀀃􀀄b 􀀏􀀍d 􀀍q 􀀕􀀓􀀓􀀐 􀀏􀀆􀀏􀀉􀀄􀀎 􀀝􀀆􀀃􀀘  \n􀀈􀀁􀀋􀀁􀀃􀀉􀀁􀀂 22 􀀛􀀍􀀚􀀏􀀍􀀜b􀀍􀀃 2025  \n􀀈􀀁􀀉􀀃􀀍􀀁􀀂 20 N􀀆􀀌􀀍􀀜b􀀍􀀃 2025  \n􀀐􀀋􀀋􀀁􀀎􀀄􀀁􀀂 26 N􀀆􀀌􀀍􀀜b􀀍􀀃 2025  \n􀀎􀀑􀀆􀀒􀀃􀀍􀀓􀀁􀀂 18 D􀀍􀀅􀀍􀀜b􀀍􀀃 2025  \n􀀋􀀃􀀄􀀐􀀄􀀃􀀌􀀏  \nF􀀕􀀏 􀀂􀀓􀀕 OAT􀀊 􀀛􀀉􀀕􀀘􀀄􀀃 NA􀀊 Z􀀕􀀂d􀀌􀀆􀀆􀀃􀀏 􀀈􀀛􀀊􀀈􀀆b􀀆 MM􀀊 􀀌􀀕􀀂 d􀀍􀀂 A􀀂􀀘􀀍􀀃 J 􀀕􀀂d 􀀞􀀕􀀃􀀏􀀓􀀍􀀐 􀀈(2025) P􀀉􀀕􀀃􀀜􀀕􀀅􀀆􀀓􀀆􀀔􀀄􀀅􀀕􀀓 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀑􀀆􀀃 􀀕􀀚􀀂􀀆􀀍􀀕􀀆􀀑 􀀚􀀃􀀍􀀜􀀕􀀏 􀀃􀀄􀀏􀀐—􀀏􀀉􀀍 􀀂􀀍􀀍d 􀀑􀀆􀀃 􀀕􀀂 􀀄􀀂d􀀄􀀌􀀄d 􀀕􀀓􀀄􀀎􀀍d 􀀕􀀚􀀚􀀃􀀆􀀕􀀅􀀉 .  \nF􀀃􀀆􀀂􀀏 . P􀀍d􀀄􀀕􀀏􀀃 . 13:1710569 .  \nd􀀆􀀄: 10.3389/􀀑􀀚􀀍d.2025.1710569  \n􀀋􀀌􀀎􀀇􀀈􀀃􀀔􀀓􀀄  \n© 2025 F􀀕􀀏 􀀂􀀓􀀕􀀊 􀀛􀀉􀀕􀀘􀀄􀀃􀀊 Z􀀕􀀂d􀀌􀀆􀀆􀀃􀀏􀀊 􀀈􀀆b􀀆􀀊 􀀌􀀕􀀂 d􀀍􀀂 A􀀂􀀘􀀍􀀃 􀀕􀀂d 􀀞􀀕􀀃􀀏􀀓􀀍􀀐 . T􀀉􀀄􀀎 􀀄􀀎 􀀕􀀂 􀀆􀀚􀀍􀀂-􀀕􀀅􀀅􀀍􀀎􀀎􀀕􀀃􀀏􀀄􀀅􀀓􀀍 d􀀄􀀎􀀏􀀃􀀄b 􀀏􀀍d 􀀂d􀀍􀀃 􀀏􀀉􀀍 􀀏􀀍􀀃􀀜􀀎 􀀆􀀑 􀀏􀀉􀀍  \n􀀈􀀃􀀍􀀕􀀏􀀄􀀌􀀍 􀀈􀀆􀀜􀀜􀀆􀀂􀀎 A􀀏􀀏􀀃􀀄b 􀀏􀀄􀀆􀀂 L􀀄􀀅􀀍􀀂􀀎􀀍 (􀀈􀀈􀀒Y) . T􀀉􀀍 􀀎􀀍􀀊 d􀀄􀀎􀀏􀀃􀀄b 􀀏􀀄􀀆􀀂 􀀆􀀃 􀀃􀀍􀀚􀀃􀀆d 􀀅􀀏􀀄􀀆􀀂 􀀄􀀂􀀆􀀏􀀉􀀍􀀃 􀀑􀀆􀀃 􀀜􀀎 􀀄􀀎 􀀚􀀍􀀃􀀜􀀄􀀏􀀏􀀍d􀀊 􀀚􀀃􀀆􀀌􀀄d􀀍d 􀀏􀀉􀀍􀀆􀀃􀀄􀀔􀀄􀀂􀀕􀀓 􀀕 􀀏􀀉􀀆􀀃(􀀎) 􀀕􀀂d 􀀏􀀉􀀍 􀀅􀀆􀀚􀀐􀀃􀀄􀀔􀀉􀀏 􀀆􀀝􀀂􀀍􀀃(􀀎)􀀕􀀃􀀍 􀀅􀀃􀀍d􀀄􀀏􀀍d 􀀕􀀂d 􀀏􀀉􀀕􀀏 􀀏􀀉􀀍 􀀆􀀃􀀄􀀔􀀄􀀂􀀕􀀓 􀀚 b􀀓􀀄􀀅􀀕􀀏􀀄􀀆􀀂􀀄􀀂 􀀏􀀉􀀄􀀎 j􀀆 􀀃􀀂􀀕􀀓 􀀄􀀎 􀀅􀀄􀀏􀀍d􀀊 􀀄􀀂 􀀕􀀅􀀅􀀆􀀃d􀀕􀀂􀀅􀀍 􀀝􀀄􀀏􀀉􀀕􀀅􀀅􀀍􀀚􀀏􀀍d 􀀕􀀅􀀕d􀀍􀀜􀀄􀀅 􀀚􀀃􀀕􀀅􀀏􀀄􀀅􀀍 . N􀀆 􀀎􀀍􀀊 d􀀄􀀎􀀏􀀃􀀄b 􀀏􀀄􀀆􀀂 􀀆􀀃 􀀃􀀍􀀚􀀃􀀆d 􀀅􀀏􀀄􀀆􀀂 􀀄􀀎 􀀚􀀍􀀃􀀜􀀄􀀏􀀏􀀍d 􀀝􀀉􀀄􀀅􀀉 d􀀆􀀍􀀎 􀀂􀀆􀀏 􀀅􀀆􀀜􀀚􀀓􀀐 􀀝􀀄􀀏􀀉 􀀏􀀉􀀍􀀎􀀍 􀀏􀀍􀀃􀀜􀀎 .  \n􀀁􀀂􀀃􀀄􀀅􀀃􀀆􀀇􀀈􀀇􀀉􀀊􀀆􀀃􀀈 􀀌􀀄􀀍􀀃􀀌􀀅􀀍􀀎􀀌 􀀏􀀇􀀄􀀃􀀐􀀎􀀇􀀍􀀃 􀀇􀀏 􀀐􀀄􀀍􀀅􀀃􀀌􀀑􀀄􀀊􀀌􀀒􀀓􀀌􀀂􀀍 􀀎􀀍􀀍􀀔􀀏􀀇􀀄 􀀃􀀎 􀀊􀀎􀀔􀀊􀀕􀀊􀀔􀀑􀀃􀀈􀀊􀀖􀀍􀀔 􀀃􀀐􀀐􀀄􀀇􀀃􀀆􀀂  \n􀀗􀀔􀀑􀀎􀀃􀀒􀀇 􀀘􀀙 􀀚􀀙 􀀛􀀃􀀌􀀑􀀎􀀈􀀃 􀀜􀀝􀀞 􀀊􀀖􀀂􀀃􀀔􀀂 􀀘􀀙 S􀀂􀀃k􀀊􀀄2􀀝􀀞 C􀀇􀀍􀀎 S􀀙 Z􀀃􀀎􀀔􀀕􀀇􀀇􀀄􀀌􀀜􀀞 M􀀃􀀄􀀊􀀃 M􀀙 C􀀇b􀀇􀀜􀀞3􀀞 J􀀇􀀂􀀎 􀀕􀀃􀀎 􀀔􀀍􀀎 􀀘􀀎k􀀍􀀄􀀜􀀞4 􀀃􀀎􀀔 C􀀃􀀄􀀇􀀈􀀊􀀎􀀍 H􀀃􀀄􀀌􀀈􀀍􀀒􀀜*  \n1 D􀀍􀀚􀀕􀀃􀀏􀀜􀀍􀀂􀀏 􀀆􀀑 P􀀕􀀍d􀀄􀀕􀀏􀀃􀀄􀀅􀀎􀀊 􀀋􀀂􀀄􀀌􀀍􀀃􀀎􀀄􀀏􀀐 􀀆􀀑 Ox􀀑􀀆􀀃d􀀊 Ox􀀑􀀆􀀃d􀀊 􀀋􀀂􀀄􀀏􀀍d K􀀄􀀂􀀔d􀀆􀀜􀀊 2M􀀍d􀀄􀀅􀀕􀀓 􀀛􀀅􀀄􀀍􀀂􀀅􀀍􀀎 D􀀄􀀌􀀄􀀎􀀄􀀆􀀂􀀊􀀋􀀂􀀄􀀌􀀍􀀃􀀎􀀄􀀏􀀐 􀀆􀀑 Ox􀀑􀀆􀀃d􀀊 Ox􀀑􀀆􀀃d􀀊 􀀋􀀂􀀄􀀏􀀍d K􀀄􀀂􀀔d􀀆􀀜􀀊 3􀀈􀀆􀀓􀀍􀀔􀀄􀀆 d􀀍 􀀈􀀄􀀍􀀂􀀅􀀄􀀕􀀎 􀀒􀀄􀀆􀀓􀀆􀀔􀀄􀀅􀀕􀀎 􀀐 A􀀜b􀀄􀀍􀀂􀀏􀀕􀀓􀀍􀀎􀀊􀀋􀀂􀀄􀀌􀀍􀀃􀀎􀀄d􀀕d 􀀛􀀕􀀂 F􀀃􀀕􀀂􀀅􀀄􀀎􀀅􀀆 d􀀍 Q 􀀄􀀏􀀆 􀀋􀀛FQ􀀊 Q 􀀄􀀏􀀆􀀊 􀀁􀀅 􀀕d􀀆􀀃􀀊 4 D􀀄􀀌􀀄􀀎􀀄􀀆􀀂 􀀆􀀑 􀀈􀀓􀀄􀀂􀀄􀀅􀀕􀀓 P􀀉􀀕􀀃􀀜􀀕􀀅􀀆􀀓􀀆􀀔􀀐􀀊􀀈􀀉􀀄􀀓d􀀃􀀍􀀂’􀀎 N􀀕􀀏􀀄􀀆􀀂􀀕􀀓 􀀞􀀆􀀎􀀚􀀄􀀏􀀕􀀓􀀊 W􀀕􀀎􀀉􀀄􀀂􀀔􀀏􀀆􀀂􀀊 D􀀈􀀊 􀀋􀀂􀀄􀀏􀀍d 􀀛􀀏􀀕􀀏􀀍􀀎  \nA􀀚􀀂􀀆􀀍􀀕—􀀏􀀉􀀍 􀀅􀀍􀀎􀀎􀀕􀀏􀀄􀀆􀀂 􀀆􀀑 b􀀃􀀍􀀕􀀏􀀉􀀄􀀂􀀔—􀀄􀀎 􀀕 􀀅􀀆􀀜􀀜􀀆􀀂 􀀅􀀆􀀂d􀀄􀀏􀀄􀀆􀀂 􀀄􀀂 􀀚􀀃􀀍􀀏􀀍􀀃􀀜 􀀄􀀂􀀑􀀕􀀂􀀏􀀎 d 􀀍 􀀏􀀆 􀀏􀀉􀀍 􀀄􀀜􀀜􀀕􀀏 􀀃􀀄􀀏􀀐 􀀆􀀑 􀀏􀀉􀀍􀀄􀀃 􀀓 􀀂􀀔􀀎􀀊 􀀕􀀄􀀃􀀝􀀕􀀐 􀀕􀀂d b􀀃􀀕􀀄􀀂􀀎􀀏􀀍􀀜 􀀃􀀍􀀎􀀚􀀄􀀃􀀕􀀏􀀆􀀃􀀐 d􀀃􀀄􀀌􀀍􀀃􀀎 .􀀈􀀆􀀂􀀎􀀍q 􀀍􀀂􀀏􀀓􀀐􀀊 􀀜􀀕􀀂􀀐 􀀚􀀃􀀍􀀏􀀍􀀃􀀜 􀀄􀀂􀀑􀀕􀀂􀀏􀀎 􀀝􀀄􀀓􀀓 􀀃􀀍􀀅􀀍􀀄􀀌􀀍 􀀚􀀉􀀕􀀃􀀜􀀕􀀅􀀆􀀓􀀆􀀔􀀄􀀅􀀕􀀓􀀄􀀂􀀏􀀍􀀃􀀌􀀍􀀂􀀏􀀄􀀆􀀂􀀎 􀀑􀀆􀀃 􀀏􀀉􀀍 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀆􀀑 􀀕􀀚􀀂􀀆􀀍􀀕 . 􀀈􀀕􀀑􀀑􀀍􀀄􀀂􀀍 (􀀆􀀃 􀀄􀀂 􀀎􀀆􀀜􀀍 d􀀍􀀌􀀍􀀓􀀆􀀚􀀄􀀂􀀔􀀅􀀆 􀀂􀀏􀀃􀀄􀀍􀀎􀀊 􀀕􀀜􀀄􀀂􀀆􀀚􀀉􀀐􀀓􀀓􀀄􀀂􀀍 􀀆􀀃 􀀏􀀉􀀍􀀆􀀚􀀉􀀐􀀓􀀓􀀄􀀂􀀍) 􀀄􀀎 􀀎 􀀕􀀓􀀓􀀐 􀀔􀀄􀀌􀀍􀀂 􀀕􀀎 fi􀀃􀀎􀀏-􀀓􀀄􀀂􀀍􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏􀀊 􀀝􀀉􀀍􀀃􀀍􀀕􀀎 d􀀆x􀀕􀀚􀀃􀀕􀀜 􀀄􀀎 􀀎􀀆􀀜􀀍􀀏􀀄􀀜􀀍􀀎 􀀎􀀍d 􀀕􀀎 􀀕􀀂 􀀕dj 􀀂􀀅􀀏 􀀏􀀉􀀍􀀃􀀕􀀚􀀐 . T􀀉􀀍􀀎􀀍 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏􀀎 􀀃􀀍d 􀀅􀀍 􀀕􀀚􀀂􀀆􀀍􀀕􀀎 􀀕􀀂d 􀀄􀀜􀀚􀀃􀀆􀀌􀀍 􀀂􀀍 􀀃􀀆d􀀍􀀌􀀍􀀓􀀆􀀚􀀜􀀍􀀂􀀏􀀕􀀓􀀆 􀀏􀀅􀀆􀀜􀀍􀀎 . 􀀞􀀆􀀝􀀍􀀌􀀍􀀃􀀊 􀀏􀀉􀀍􀀃􀀍 􀀄􀀎 􀀎 b􀀎􀀏􀀕􀀂􀀏􀀄􀀕􀀓 􀀌􀀕􀀃􀀄􀀕􀀏􀀄􀀆􀀂 􀀄􀀂 􀀄􀀂d􀀄􀀌􀀄d 􀀕􀀓 􀀄􀀂􀀑􀀕􀀂􀀏􀀎’􀀃􀀍q 􀀄􀀃􀀍􀀜􀀍􀀂􀀏 􀀑􀀆􀀃 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 (􀀂􀀆􀀏 􀀕􀀓􀀓 􀀄􀀂􀀑􀀕􀀂􀀏􀀎 􀀝􀀄􀀓􀀓 􀀍x􀀚􀀍􀀃􀀄􀀍􀀂􀀅􀀍 􀀕􀀚􀀂􀀆􀀍􀀕 􀀂􀀆􀀃 􀀏􀀆 􀀏􀀉􀀍􀀎􀀕􀀜􀀍 d􀀍􀀔􀀃􀀍􀀍) . M􀀆􀀃􀀍􀀆􀀌􀀍􀀃􀀊 􀀏􀀉􀀍􀀃􀀍 􀀕􀀃􀀍 􀀅􀀆􀀂􀀎􀀄d􀀍􀀃􀀕b􀀓􀀍 d􀀄􀀑􀀑􀀍􀀃􀀍􀀂􀀅􀀍􀀎 􀀄􀀂 􀀉􀀆􀀝 􀀄􀀂􀀑􀀕􀀂􀀏􀀎􀀃􀀍􀀎􀀚􀀆􀀂d 􀀏􀀆 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏􀀊 􀀑􀀆􀀃 􀀍x􀀕􀀜􀀚􀀓􀀍􀀊 􀀎􀀆􀀜􀀍 􀀄􀀂􀀑􀀕􀀂􀀏􀀎 􀀅􀀆􀀂􀀏􀀄􀀂 􀀍 􀀏􀀆 􀀍x􀀚􀀍􀀃􀀄􀀍􀀂􀀅􀀍􀀍􀀚􀀄􀀎􀀆d􀀍􀀎 􀀆􀀑 􀀕􀀚􀀂􀀆􀀍􀀕 d􀀍􀀎􀀚􀀄􀀏􀀍 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 . 􀀈􀀓􀀄􀀂􀀄􀀅􀀕􀀓 􀀔 􀀄d􀀍􀀓􀀄􀀂􀀍􀀎 􀀑􀀆􀀃 􀀚􀀉􀀕􀀃􀀜􀀕􀀅􀀆􀀓􀀆􀀔􀀄􀀅􀀕􀀓􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 (􀀄􀀂 􀀚􀀕􀀃􀀏􀀄􀀅 􀀓􀀕􀀃􀀊 􀀑􀀆􀀃 􀀅􀀕􀀑􀀑􀀍􀀄􀀂􀀍) 􀀕􀀃􀀍 􀀆􀀑􀀏􀀍􀀂 b􀀕􀀎􀀍d 􀀆􀀂 􀀏􀀉􀀍 􀀕􀀔􀀍 􀀆􀀃 􀀝􀀍􀀄􀀔􀀉􀀏 􀀆􀀑􀀏􀀉􀀍 􀀄􀀂􀀑􀀕􀀂􀀏􀀊 􀀕􀀂d 􀀏􀀉􀀍􀀃􀀍 􀀕􀀃􀀍 􀀅 􀀃􀀃􀀍􀀂􀀏􀀓􀀐 􀀂􀀆 b􀀄􀀆􀀜􀀕􀀃􀀘􀀍􀀃􀀎 􀀑􀀆􀀃 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀃􀀍q 􀀄􀀃􀀍􀀜􀀍􀀂􀀏􀀆􀀃 d􀀆􀀎􀀄􀀂􀀔 . T􀀉􀀍􀀃􀀍 􀀄􀀎 􀀕 􀀂􀀍􀀍d 􀀑􀀆􀀃 􀀚􀀍􀀃􀀎􀀆􀀂􀀕􀀓􀀄􀀎􀀍d 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀑􀀆􀀃 􀀕􀀚􀀂􀀆􀀍􀀕 􀀆􀀑􀀚􀀃􀀍􀀜􀀕􀀏 􀀃􀀄􀀏􀀐 􀀏􀀉􀀃􀀆 􀀔􀀉 􀀏􀀉􀀍 􀀄d􀀍􀀂􀀏􀀄fi􀀅􀀕􀀏􀀄􀀆􀀂 􀀆􀀑 􀀎 􀀄􀀏􀀕b􀀓􀀍 􀀚􀀉􀀕􀀃􀀜􀀕􀀅􀀆d􀀐􀀂􀀕􀀜􀀄􀀅 b􀀄􀀆􀀜􀀕􀀃􀀘􀀍􀀃􀀎 . 􀀞􀀍􀀃􀀍 􀀝􀀍 􀀂􀀕􀀃􀀃􀀕􀀏􀀄􀀌􀀍􀀓􀀐 􀀃􀀍􀀌􀀄􀀍􀀝 􀀅 􀀃􀀃􀀍􀀂􀀏 􀀘􀀂􀀆􀀝􀀓􀀍d􀀔􀀍 􀀆􀀑 􀀏􀀉􀀍 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀆􀀑􀀕􀀚􀀂􀀆􀀍􀀕􀀊 􀀑􀀆􀀅 􀀎􀀄􀀂􀀔 􀀆􀀂 􀀅􀀕􀀑􀀑􀀍􀀄􀀂􀀍􀀊 􀀕􀀜􀀄􀀂􀀆􀀚􀀉􀀐􀀓􀀓􀀄􀀂􀀍 􀀕􀀂d d􀀆x􀀕􀀚􀀃􀀕􀀜 . W􀀍 􀀚􀀃􀀆􀀚􀀆􀀎􀀍􀀚􀀆􀀏􀀍􀀂􀀏􀀄􀀕􀀓 􀀚􀀉􀀕􀀃􀀜􀀕􀀅􀀆d􀀐􀀂􀀕􀀜􀀄􀀅 b􀀄􀀆􀀜􀀕􀀃􀀘􀀍􀀃􀀎 􀀕􀀂d 􀀍x􀀚􀀓􀀆􀀃􀀍 􀀕􀀌􀀍􀀂 􀀍􀀎 􀀑􀀆􀀃 􀀑 􀀏 􀀃􀀍􀀃􀀍􀀎􀀍􀀕􀀃􀀅􀀉 􀀝􀀉􀀄􀀅􀀉 􀀝􀀄􀀓􀀓 􀀍􀀂􀀕b􀀓􀀍 􀀏􀀉􀀍 􀀏􀀍􀀎􀀏􀀄􀀂􀀔 􀀕􀀂d 􀀏􀀃􀀕􀀂􀀎􀀓􀀕􀀏􀀄􀀆􀀂 􀀆􀀑 􀀏􀀉􀀍􀀎􀀍 b􀀄􀀆􀀜􀀕􀀃􀀘􀀍􀀃􀀎 􀀑􀀆􀀃􀀎􀀍 􀀄􀀂 􀀏􀀉􀀍 􀀂􀀍􀀆􀀂􀀕􀀏􀀕􀀓 􀀂􀀄􀀏 . A 􀀚􀀍􀀃􀀎􀀆􀀂􀀕􀀓􀀄􀀎􀀍d 􀀕􀀚􀀚􀀃􀀆􀀕􀀅􀀉 􀀑􀀆􀀃 􀀕􀀚􀀂􀀆􀀍􀀕 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀄􀀎  \n􀀍􀀎􀀎􀀍􀀂􀀏􀀄􀀕􀀓 􀀏􀀆 􀀜􀀄􀀏􀀄􀀔􀀕􀀏􀀍 􀀏􀀉􀀍 􀀂􀀍􀀔􀀕􀀏􀀄􀀌􀀍 􀀎􀀉􀀆􀀃􀀏 􀀕􀀂d 􀀓􀀆􀀂􀀔-􀀏􀀍􀀃􀀜 􀀍􀀑􀀑􀀍􀀅􀀏􀀎 􀀆􀀑 b􀀆􀀏􀀉 􀀕􀀚􀀂􀀆􀀍􀀕􀀕􀀂d 􀀄􀀏􀀎 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀄􀀂 􀀚􀀃􀀍􀀜􀀕􀀏 􀀃􀀍 􀀄􀀂􀀑􀀕􀀂􀀏􀀎􀀊 􀀍􀀂􀀎 􀀃􀀄􀀂􀀔 􀀏􀀉􀀕􀀏 􀀏􀀃􀀍􀀕􀀏􀀜􀀍􀀂􀀏 􀀅􀀕􀀂 b􀀍􀀚􀀃􀀆􀀌􀀄d􀀍d 􀀕􀀏 􀀏􀀉􀀍 􀀃􀀄􀀔􀀉􀀏 􀀏􀀄􀀜􀀍 􀀕􀀂d 􀀝􀀄􀀏􀀉 􀀏􀀉􀀍 􀀅􀀆􀀃􀀃􀀍􀀅􀀏 d􀀆􀀎􀀍 .  \n􀀕􀀁􀀇􀀊􀀌􀀈􀀂􀀍  \n􀀖􀀗􀀘􀀙􀀚􀀖􀀛 􀀜􀀖􀀝􀀝􀀚􀀞􀀘􀀚􀀛 􀀙x􀀖􀀗r􀀖m􀀛 􀀗r􀀚t􀀚rm􀀛 􀀖m􀀞􀀘􀀙􀀗hyll􀀞􀀘􀀚􀀛 􀀁􀀁􀀔􀀛 v􀀞t􀀖l s􀀞g􀀘s􀀛 b􀀞􀀙m􀀖rk􀀚r  \nI􀀎􀀌􀀄􀀇􀀔􀀑􀀆􀀌􀀊􀀇􀀎  \n􀀁􀀂􀀃􀀄􀀅􀀆 􀀄􀀈 􀀂􀀉􀀅􀀊􀀆􀀋􀀌􀀉􀀍􀀋􀀎 􀀏􀀁􀀐􀀑􀀒 􀀍􀀓 􀀄􀀈􀀋􀀅􀀃 􀀔􀀅􀀕􀀃􀀅􀀔 􀀖􀀗􀀍􀀃􀀍􀀖􀀆􀀗􀀗􀀎 􀀆􀀓 􀀆 􀀂􀀆􀀌􀀓􀀅 􀀍􀀃 􀀘􀀉􀀅􀀆􀀋􀀙􀀍􀀃􀀚 􀀄􀀈􀀊􀀄􀀉􀀅 􀀋􀀙􀀆􀀃 􀀛􀀜 􀀓􀀝 􀀄􀀉 􀀆 􀀓􀀙􀀄􀀉􀀋􀀅􀀉 􀀂􀀆􀀌􀀓􀀅 􀀋􀀙􀀆􀀋 􀀍􀀓 􀀆􀀓􀀓􀀄􀀖􀀍􀀆􀀋􀀅􀀔 􀀞􀀍􀀋􀀙 􀀖􀀎􀀆􀀃􀀄􀀓􀀍􀀓 􀀄􀀉 􀀘􀀉􀀆􀀔􀀎􀀖􀀆􀀉􀀔􀀍􀀆􀀝 􀀍􀀃􀀆􀀃 􀀍􀀃􀀈􀀆􀀃􀀋 􀀘􀀄􀀉􀀃 􀀘􀀅􀀈􀀄􀀉􀀅 7 􀀞􀀅􀀅k􀀓’ 􀀚􀀅􀀓􀀋􀀆􀀋􀀍􀀄􀀃 􀀏1􀀝 􀀛􀀒 . 􀀁􀀐􀀑 􀀍􀀓 􀀖􀀄􀀊􀀊􀀄􀀃􀀝 􀀆􀀈􀀈􀀅􀀖􀀋􀀍􀀃􀀚 􀀆􀀉􀀄􀀌􀀃􀀔 9􀀜% 􀀄􀀈 􀀍􀀃􀀈􀀆􀀃􀀋􀀓 􀀘􀀄􀀉􀀃 􀀞􀀅􀀍􀀚􀀙􀀍􀀃􀀚 􀀗􀀅􀀓􀀓 􀀋􀀙","cbCailt2NzyYxIDe","https://ap.wps.com/l/cbCailt2NzyYxIDe","pdf",537314,12,"English","# Introduction\n## Rationale for individualized pharmacological management\n## Treatment considerations and outcomes\n## Clinical implications and implementation","[{\"question\":\"Why is an individualized pharmacological approach important for apnea of prematurity?\",\"answer\":\"Because treatment decisions need to account for patient-specific risk factors and therapeutic goals, balancing expected benefits against potential harms.\"},{\"question\":\"What factors are considered when choosing pharmacological therapy?\",\"answer\":\"The article emphasizes clinical reasoning around outcomes, dosing considerations, and monitoring needs tailored to the individual infant.\"},{\"question\":\"How does the article apply its conclusions to clinical practice?\",\"answer\":\"It frames individualized decision-making as a practical requirement, supporting clinicians to select and supervise treatment in line with evolving evidence and patient characteristics.\"}]","Pharmacological treatment for apnoea of prematurity - the need for an individualised approach | PDF",1790588055]